SOMATROPIN Side Effects

7006089-8 | Limb Malformation
on Sep 09, 2010 Male patient from UNITED KINGDOM , child 11 years of age, was diagnosed with hypopituitarism and was treated with Somatropin (View Usage). Patient experienced the following unwanted or unexpected effects: limb malformation. Somatropin dosage: 0.9 Mg, 1x/day. Patient was hospitalized.

7002666-9 | Osteoarthritis, Tendon Rupture
Patient was taking Somatropin (View Usage). Patient had the following side effects: osteoarthritis (What is osteoarthritis?), tendon rupture on Sep 07, 2010 from UNITED STATES Additional patient health information: Female patient , weighting 183.0 lb, was diagnosed with lymphocytic hypophysitis and. Somatropin dosage: 0.4 Mg, Daily (1/d). During the same period patient was treated with POLYGAM S/D (35 G, 4/w) (View Polygam S/d Review and Polygam S/d Label ), EVOXAC (30 Mg, 3/d) (View Evoxac Review and Evoxac Label ), AVAPRO (300 Mg, Daily (1/d)) (View Avapro Review and Avapro Label ), HYDROCHLOROTHIAZIDE (25 Mg, Daily (1/d)) (View Hydrochlorothiazide Review and Hydrochlorothiazide Label ), PROTONIX (40 Mg, 2/d) (View Protonix Review and Protonix Label ), ZANTAC (300 Mg, As Needed) (View Zantac Review and Zantac Label ), SYNTHROID (75 Mg, Other) (View Synthroid Review and Synthroid Label ). Patient was hospitalized.

7000092-X | Abortion Spontaneous, Hemiparesis
Adverse event was reported on Sep 06, 2010 by a Female patient taking Somatropin (View Usage) (Dosage: 0.4 Mg, Daily (1/d)) was diagnosed with growth hormone deficiency, hyperadrenocorticism, osteopenia and. Location: UNITED KINGDOM , weighting 147.5 lb, After Somatropin was administered, patient had the following side effects: abortion spontaneous, hemiparesis. During the same period patient was treated with HYDROCORTISONE (View Hydrocortisone Review and Hydrocortisone Label ), ADCAL D3 (View Adcal D3 Review and Adcal D3 Label ). Patient was hospitalized.

6991890-7 | Dysphagia, Pharyngitis Streptococcal, Vomiting
on Sep 07, 2010 Female patient from FRANCE , 15 years of age, weighting 143.3 lb, was diagnosed with hypopituitarism and was treated with Somatropin (View Usage). Patient experienced the following unwanted or unexpected effects: dysphagia, pharyngitis streptococcal, vomiting. Somatropin dosage: Unk. During the same period patient was treated with LEVOTHYROXINE SODIUM (100 Ug, 1x/day) (View Levothyroxine Sodium Review and Levothyroxine Sodium Label ), ROCEPHIN (1.5 G, 1x/day) (View Rocephin Review and Rocephin Label ). Patient was hospitalized.


6991495-8 | Basal Cell Carcinoma
on Sep 02, 2010 Female patient from SWEDEN , weighting 153.2 lb, was diagnosed with growth hormone deficiency, adrenal insufficiency and was treated with Somatropin (View Usage). Patient had the following side effects: basal cell carcinoma. Somatropin dosage: 0.6 Mg, Daily (1/d). During the same period patient was treated with LEVOTHYROXINE SODIUM (100 Ug, Daily (1/d)) (View Levothyroxine Sodium Review and Levothyroxine Sodium Label ), HYDROCORTISONE (25 Mg, Daily (1/d)) (View Hydrocortisone Review and Hydrocortisone Label ), PRASTERONE (25 Mg, Daily (1/d)) (View Prasterone Review and Prasterone Label ).

6988549-9 | Intracranial Pressure Increased, Metabolic Acidosis
Patient was taking Somatropin (View Usage). After Somatropin was administered, patient had the following side effects: intracranial pressure increased, metabolic acidosis on Sep 16, 2010 from ITALY Additional patient health information: Female patient , child 9 years of age, weighting 54.23 lb, was diagnosed with growth hormone deficiency and. Somatropin dosage: 6 Mg, Weekly (1/w). Patient was hospitalized.

6983883-0 | Pituitary Tumour Benign
Adverse event was reported on Sep 01, 2010 by a Male patient taking Somatropin (View Usage) (Dosage: ) was diagnosed with pituitary tumour benign, hypertension, arthralgia, hypopituitarism and. Location: GERMANY , weighting 193.6 lb, Patient experienced the following unwanted or unexpected effects: pituitary tumour benign. During the same period patient was treated with IRBESARTAN (150 Mg, Unk) (View Irbesartan Review and Irbesartan Label ), ALLOPURINOL (150 Mg, Unk) (View Allopurinol Review and Allopurinol Label ), HYDROCORTISONE (25 Mg, Unk) (View Hydrocortisone Review and Hydrocortisone Label ), NEBIDO (1000 Mg, Unk) (View Nebido Review and Nebido Label ), COAPROVEL (225 Mg, Unk) (View Coaprovel Review and Coaprovel Label ). Patient was hospitalized.

6979437-2 | Benign Intracranial Hypertension
on Sep 01, 2010 Male patient from UNITED STATES , weighting 20.28 lb, was diagnosed with congenital cystic kidney disease, growth retardation and was treated with Somatropin (View Usage). Patient had the following side effects: benign intracranial hypertension. Somatropin dosage: 0.44 Mg, 7/week. During the same period patient was treated with CACO3 (0.5 Unk, Unk) (View Caco3 Review and Caco3 Label ), EPOGEN (1600 Unk, Unk) (View Epogen Review and Epogen Label ), FERINSOL (0.8 Ml, Unk) (View Ferinsol Review and Ferinsol Label ), LEVOTHYROXINE (0.25 Unk, Unk) (View Levothyroxine Review and Levothyroxine Label ), NA PHOSPHATE (0.75 Unk, Unk) (View Na Phosphate Review and Na Phosphate Label ), REGLAN (1 Unk, Unk) (View Reglan Review and Reglan Label ), MUPIROCIN (View Mupirocin Review and Mupirocin Label ). Patient was hospitalized.

6973718-4 | Protein-losing Gastroenteropathy
on Aug 30, 2010 Male patient from CANADA , 16 years of age, was diagnosed with body height below normal and was treated with Somatropin (View Usage). After Somatropin was administered, patient had the following side effects: protein-losing gastroenteropathy. Somatropin dosage: 0.24 Mg/kg, Weekly. During the same period patient was treated with SPIRONOLACTONE (3-4mg/kg/day Divided Into 4 Doses) (View Spironolactone Review and Spironolactone Label ), SPIRONOLACTONE W/ HYDROCHLOROTHIAZIDE (1-3mg/kg/day Divided Into 2 Doses) (View Spironolactone W/ Hydrochlorothiazide Review and Spironolactone W/ Hydrochlorothiazide Label ).

6969007-4 | Haemoptysis, Pulmonary Embolism
Patient was taking Somatropin (View Usage). Patient experienced the following unwanted or unexpected effects: haemoptysis, pulmonary embolism (What is pulmonary embolism?) on Aug 25, 2010 from SWEDEN Additional patient health information: Male patient , 37 years of age, weighting 207.2 lb, was diagnosed with hypopituitarism, hypothyroidism and. Somatropin dosage: 0.4 Mg, 1xday, 7 Injections/week. During the same period patient was treated with AMLODIPINE (10 Mg, 1x/day) (View Amlodipine Review and Amlodipine Label ), LEVOTHYROXINE (100ug/day) (View Levothyroxine Review and Levothyroxine Label ). Patient was hospitalized.

6965063-8 | Pituitary Tumour Benign
Adverse event was reported on Aug 24, 2010 by a Male patient taking Somatropin (View Usage) (Dosage: 0.6 Mg, Daily (1/d)) was diagnosed with pituitary tumour benign and. Location: FRANCE , weighting 216.1 lb, Patient had the following side effects: pituitary tumour benign. During the same period patient was treated with UMATROPE (View Umatrope Review and Umatrope Label ). Patient was hospitalized.

6958177-X | Pituitary Tumour
on Aug 19, 2010 Female patient from GERMANY , 50 years of age, weighting 238.1 lb, was diagnosed with hypopituitarism and was treated with Somatropin (View Usage). After Somatropin was administered, patient had the following side effects: pituitary tumour. Somatropin dosage: 0.6 Mg, 1x/day. Patient was hospitalized.

6958153-7 | Abdominal Pain
on Aug 19, 2010 Female patient from UNITED KINGDOM , 54 years of age, weighting 163.1 lb, was diagnosed with dysthymic disorder, primary hypothyroidism, blood thyroid stimulating hormone decreased and was treated with Somatropin (View Usage). Patient experienced the following unwanted or unexpected effects: abdominal pain (What is abdominal pain?). Somatropin dosage: 0.53 Mg, 1x/day (7 Injections Per Week). During the same period patient was treated with NIZATIDINE (50 Mg, Unk) (View Nizatidine Review and Nizatidine Label ), SULPIRIDE (200 Mg, Daily) (View Sulpiride Review and Sulpiride Label ), IMIPRAMINE (100 Mg, Daily) (View Imipramine Review and Imipramine Label ), BISACODYL (10 Mg, Daily) (View Bisacodyl Review and Bisacodyl Label ), LEVOTHYROXINE (125 Mg, Daily) (View Levothyroxine Review and Levothyroxine Label ), EFFEXOR (1 Df, Daily) (View Effexor Review and Effexor Label ). Patient was hospitalized.

6958138-0 | Metastases To Lymph Nodes, Rectal Cancer Stage Iii
Patient was taking Somatropin (View Usage). Patient had the following side effects: metastases to lymph nodes, rectal cancer stage iii on Aug 19, 2010 from SWEDEN Additional patient health information: Female patient , 62 years of age, was diagnosed with hypopituitarism and. Somatropin dosage: 0.2 Mg, 1x/day. During the same period patient was treated with ATACAND (16 Mg, 1x/day) (View Atacand Review and Atacand Label ), SIMVASTATIN (20 Mg, 2x/day At Night) (View Simvastatin Review and Simvastatin Label ), LEVOTHYROXINE SODIUM (50 Ug, 1x/day) (View Levothyroxine Sodium Review and Levothyroxine Sodium Label ), HYDROCORTISONE ^NYCOMED^ (30 Mg, Daily) (View Hydrocortisone ^nycomed^ Review and Hydrocortisone ^nycomed^ Label ), MINIRIN ^AVENTIS PHARMA^ (60 Ug, 1x/day At Night) (View Minirin ^aventis Pharma^ Review and Minirin ^aventis Pharma^ Label ). Patient was hospitalized.

6956920-7 | Protein-losing Gastroenteropathy
Adverse event was reported on Aug 23, 2010 by a Male patient taking Somatropin (View Usage) (Dosage: 0.18 Mg/kg, 1/week) was diagnosed with growth hormone deficiency and. Location: UNITED KINGDOM , 13 years of age, After Somatropin was administered, patient had the following side effects: protein-losing gastroenteropathy. During the same period patient was treated with ALDACTAZIDE (Unk Mg/kg, Qd) (View Aldactazide Review and Aldactazide Label ), SPIRONOLACTONE (Unk Mg/kg, Qd) (View Spironolactone Review and Spironolactone Label ), FUROSEMIDE (View Furosemide Review and Furosemide Label ).

6955483-X | Type 1 Diabetes Mellitus
on Aug 18, 2010 Male patient from GERMANY , child 6 years of age, weighting 36.38 lb, was diagnosed with small for dates baby and was treated with Somatropin (View Usage). Patient experienced the following unwanted or unexpected effects: type 1 diabetes mellitus. Somatropin dosage: 0.5 Mg, 1x/day.

6943378-7 | Metastases To Liver, Small Intestine Carcinoma
on Aug 17, 2010 Male patient from UNITED KINGDOM , 67 years of age, weighting 280.4 lb, was diagnosed with hypopituitarism, hypothyroidism, blood luteinising hormone decreased, blood follicle stimulating hormone decreased, hypogonadism male, blood corticotrophin decreased, gastric ulcer, duodenal ulcer and was treated with Somatropin (View Usage). Patient had the following side effects: metastases to liver, small intestine carcinoma. Somatropin dosage: 0.3 Mg, 1x/day. During the same period patient was treated with LEVOTHYROXINE SODIUM (100 Ug, 1x/day) (View Levothyroxine Sodium Review and Levothyroxine Sodium Label ), SUSTANON (1 Ml, Unk) (View Sustanon Review and Sustanon Label ), HYDROCORTISONE (30 Mg, 1x/day) (View Hydrocortisone Review and Hydrocortisone Label ), OMEPRAZOLE (10 Mg, 1x/day) (View Omeprazole Review and Omeprazole Label ). Patient was hospitalized.

6940412-5 | Adenoidal Hypertrophy, Sleep Apnoea Syndrome
Patient was taking Somatropin (View Usage). After Somatropin was administered, patient had the following side effects: adenoidal hypertrophy, sleep apnoea syndrome on Aug 13, 2010 from CANADA Additional patient health information: Female patient , weighting 78.48 lb, was diagnosed with turner's syndrome and. Somatropin dosage: 1.6 Mg, Daily (1/d). Patient was hospitalized.

6940410-1 | Meningioma
Adverse event was reported on Aug 13, 2010 by a Male patient taking Somatropin (View Usage) (Dosage: 1.35 Mg, Daily (1/d)) was diagnosed with growth hormone deficiency, hypothyroidism and. Location: CANADA , weighting 117.5 lb, Patient experienced the following unwanted or unexpected effects: meningioma. During the same period patient was treated with SYNTHROID (View Synthroid Review and Synthroid Label ). Patient was hospitalized.

6938558-0 | Medulloblastoma Recurrent
on Apr 28, 2009 Male patient from CANADA , weighting 71.87 lb, was diagnosed with growth hormone deficiency, hypothyroidism and was treated with Somatropin (View Usage). Patient had the following side effects: medulloblastoma recurrent. Somatropin dosage: 0.96 Mg, 6/w. During the same period patient was treated with LEVOTHYROXINE SODIUM (View Levothyroxine Sodium Review and Levothyroxine Sodium Label ). Patient was hospitalized and became disabled.

6930265-3 | Non-secretory Adenoma Of Pituitary
on Aug 05, 2010 Male patient from JAPAN , weighting 138.9 lb, was diagnosed with growth hormone deficiency and was treated with Somatropin (View Usage). After Somatropin was administered, patient had the following side effects: non-secretory adenoma of pituitary. Somatropin dosage: 0.2 Mg, Daily (1/d). Patient was hospitalized.

6930259-8 | Basal Cell Carcinoma
Patient was taking Somatropin (View Usage). Patient experienced the following unwanted or unexpected effects: basal cell carcinoma on Aug 13, 2010 from SWEDEN Additional patient health information: Female patient , weighting 153.2 lb, was diagnosed with growth hormone deficiency, adrenal insufficiency and. Somatropin dosage: 0.6 Mg, Daily (1/d). During the same period patient was treated with LEVOTHYROXINE SODIUM (100 Ug, Daily (1/d)) (View Levothyroxine Sodium Review and Levothyroxine Sodium Label ), HYDROCORTISONE (25 Mg, Daily (1/d)) (View Hydrocortisone Review and Hydrocortisone Label ), PRASTERONE (25 Mg, Daily (1/d)) (View Prasterone Review and Prasterone Label ).

6920340-1 | Pituitary-dependent Cushing's Syndrome
Adverse event was reported on Jul 21, 2009 by a Male patient taking Somatropin (View Usage) (Dosage: ) was diagnosed with body height below normal and. Location: UNITED STATES , child 11 years of age, Patient had the following side effects: pituitary-dependent cushing's syndrome. During the same period patient was treated with METFORMIN (View Metformin Review and Metformin Label ). Patient was hospitalized.

6920339-5 | Hypersensitivity, Rash
on May 29, 2009 Female patient from UNITED STATES , weighting 165.0 lb, was diagnosed with myalgia and was treated with Somatropin (View Usage). After Somatropin was administered, patient had the following side effects: hypersensitivity, rash (What is rash?). Somatropin dosage: 0.4 Mg 6x/week. During the same period patient was treated with THYROID (View Thyroid Review and Thyroid Label ), CORTISONE ACETATE (View Cortisone Acetate Review and Cortisone Acetate Label ), DAILY MULTIVITAMIN (View Daily Multivitamin Review and Daily Multivitamin Label ), POLICOSANOL (View Policosanol Review and Policosanol Label ), CALCIFEROL (View Calciferol Review and Calciferol Label ), ASPIRINE (View Aspirine Review and Aspirine Label ), CALCITONIN SALMON (View Calcitonin-salmon Review and Calcitonin-salmon Label ).

6918907-X | Rathke's Cleft Cyst
on Jul 28, 2010 Female patient from GERMANY , weighting 85.10 lb, was diagnosed with growth hormone deficiency and was treated with Somatropin (View Usage). Patient experienced the following unwanted or unexpected effects: rathke's cleft cyst. Somatropin dosage: 1.1 Mg, Daily (1/d). Patient was hospitalized.

6918627-1 | Osteonecrosis
Patient was taking Somatropin (View Usage). Patient had the following side effects: osteonecrosis (What is osteonecrosis?) on Jul 30, 2010 from COLOMBIA Additional patient health information: Female patient , child 12 years of age, was diagnosed with turner's syndrome and. Somatropin dosage: 1.6 Mg, 1x/day.

6916273-7 |
Adverse event was reported on Jul 29, 2010 by a Male patient taking Somatropin (View Usage) (Dosage: 0.3 Mg, 1x/day) was diagnosed with hypopituitarism, hypothyroidism, blood luteinising hormone decreased, blood follicle stimulating hormone decreased, hypogonadism male, blood corticotrophin decreased, gastric ulcer, duodenal ulcer and. Location: UNITED KINGDOM , 67 years of age, weighting 280.4 lb, . During the same period patient was treated with LEVOTHYROXINE SODIUM (100 Ug, 1x/day) (View Levothyroxine Sodium Review and Levothyroxine Sodium Label ), SUSTANON (1 Ml, Unk) (View Sustanon Review and Sustanon Label ), HYDROCORTISONE (30 Mg, 1x/day) (View Hydrocortisone Review and Hydrocortisone Label ), OMEPRAZOLE (10 Mg, 1x/day) (View Omeprazole Review and Omeprazole Label ). Patient was hospitalized.

6916265-8 | Neoplasm Recurrence, Oligodendroglioma
on Jul 29, 2010 Female patient from UNITED KINGDOM , 46 years of age, weighting 216.1 lb, was diagnosed with hypopituitarism, blood thyroid stimulating hormone decreased, primary hypothyroidism, blood corticotrophin decreased and was treated with Somatropin (View Usage). Patient experienced the following unwanted or unexpected effects: neoplasm recurrence, oligodendroglioma. Somatropin dosage: 0.3 Mg, 1x/day. During the same period patient was treated with LEVOTHYROXINE (25 Ug, 1x/day) (View Levothyroxine Review and Levothyroxine Label ), VALPROATE SODIUM (500 Ug, 1x/day) (View Valproate Sodium Review and Valproate Sodium Label ), HYDROCORTISONE (15 Mg, 1x/day) (View Hydrocortisone Review and Hydrocortisone Label ). Patient was hospitalized.

6905639-7 | Neoplasm Recurrence, Oligodendroglioma
on Jul 23, 2010 Female patient from UNITED KINGDOM , 46 years of age, weighting 216.1 lb, was diagnosed with hypopituitarism, blood thyroid stimulating hormone decreased, primary hypothyroidism, blood corticotrophin decreased and was treated with Somatropin (View Usage). Patient had the following side effects: neoplasm recurrence, oligodendroglioma. Somatropin dosage: 0.3 Mg, 1x/day. During the same period patient was treated with LEVOTHYROXINE (25 Ug, 1x/day) (View Levothyroxine Review and Levothyroxine Label ), VALPROATE SODIUM (500 Ug, 1x/day) (View Valproate Sodium Review and Valproate Sodium Label ), HYDROCORTISONE (15 Mg, 1x/day) (View Hydrocortisone Review and Hydrocortisone Label ). Patient was hospitalized.

6900435-9 | Brain Neoplasm
Patient was taking Somatropin (View Usage). After Somatropin was administered, patient had the following side effects: brain neoplasm on Jul 22, 2010 from JAPAN Additional patient health information: Female patient , child 5 years of age, was diagnosed with small for dates baby and. Somatropin dosage: Unk.

6896313-4 | Viith Nerve Paralysis
Adverse event was reported on Jul 23, 2010 by a Female patient taking Somatropin (View Usage) (Dosage: 0.6 Mg, Qd) was diagnosed with growth hormone deficiency and. Location: UNITED STATES , child 6 years of age, weighting 39.24 lb, Patient experienced the following unwanted or unexpected effects: viith nerve paralysis.

6881824-8 | Abdominal Pain
on Jul 20, 2010 Male patient from FRANCE , 15 years of age, weighting 81.79 lb, was diagnosed with growth hormone deficiency and was treated with Somatropin (View Usage). Patient had the following side effects: abdominal pain (What is abdominal pain?). Somatropin dosage: 9.60 Mg, Weekly. Patient was hospitalized.

6878293-0 |
on Jul 16, 2010 Male patient from UNITED KINGDOM , 67 years of age, was treated with Somatropin (View Usage). . Somatropin dosage: 0.3 Mg, 1x/day.

6876459-7 | Otitis Media, Tonsillar Disorder
Patient was taking Somatropin (View Usage). Patient experienced the following unwanted or unexpected effects: otitis media, tonsillar disorder on Jul 16, 2010 from JAPAN Additional patient health information: Female patient , child 6 years of age, weighting 31.17 lb, was diagnosed with small for dates baby and. Somatropin dosage: 0.7 Mg, 1x/day. Patient was hospitalized.

6872287-7 | Cardiac Failure
Adverse event was reported on Jul 12, 2010 by a Female patient taking Somatropin (View Usage) (Dosage: 0.2 U, Qd) was diagnosed with growth hormone deficiency, ovarian failure, hypothyroidism, hypoparathyroidism and. Location: UNITED KINGDOM , 25 years of age, Patient had the following side effects: cardiac failure. During the same period patient was treated with ESTRADIOL (Unk, Unk) (View Estradiol Review and Estradiol Label ), PROGESTERONE (Unk, Unk) (View Progesterone Review and Progesterone Label ), LEVOTHYROXINE SODIUM (150 A?g, Unk) (View Levothyroxine Sodium Review and Levothyroxine Sodium Label ), CALCIUM D3 (Unk, Unk) (View Calcium D3 Review and Calcium D3 Label ), ALLOPURINOL (View Allopurinol Review and Allopurinol Label ). Patient was hospitalized.

6872143-4 | Craniopharyngioma, Neoplasm Progression
on Jul 15, 2010 Female patient from UNITED STATES , weighting 140.4 lb, was diagnosed with growth hormone deficiency and was treated with Somatropin (View Usage). After Somatropin was administered, patient had the following side effects: craniopharyngioma, neoplasm progression. Somatropin dosage: 1.7 Mg, Qd. During the same period patient was treated with ESTROGEN PATCH (50 A?g, Unk) (View Estrogen Patch Review and Estrogen Patch Label ), SYNTHROID (88 A?g, Qd) (View Synthroid Review and Synthroid Label ), PROGESTERONE (10 Mg, Unk) (View Progesterone Review and Progesterone Label ), HYDROCORTISONE (20 Mg, Prn) (View Hydrocortisone Review and Hydrocortisone Label ), DDAVP (Unk) (View Ddavp Review and Ddavp Label ).

6872142-2 | Bacteraemia, Respiratory Distress, Septic Shock
on Jul 15, 2010 Male patient from UNITED STATES , weighting 99.21 lb, was diagnosed with growth hormone deficiency and was treated with Somatropin (View Usage). Patient experienced the following unwanted or unexpected effects: bacteraemia, respiratory distress, septic shock. Somatropin dosage: 0.1 Mg, Qd. During the same period patient was treated with LEVOTHYROXINE SODIUM (75 A?g, Qd) (View Levothyroxine Sodium Review and Levothyroxine Sodium Label ), HYDROCORTISONE (5 Mg, Bid) (View Hydrocortisone Review and Hydrocortisone Label ), NEURONTIN (Unk) (View Neurontin Review and Neurontin Label ), TESTOSTERONE PATCH (2.5 Mg, Qd) (View Testosterone Patch Review and Testosterone Patch Label ), KEPPRA (500 Mg, Bid) (View Keppra Review and Keppra Label ), CLONAZEPAM (1 Mg, Qd) (View Clonazepam Review and Clonazepam Label ). Patient was hospitalized.

6872139-2 | Viith Nerve Paralysis
Patient was taking Somatropin (View Usage). Patient had the following side effects: viith nerve paralysis on Jul 15, 2010 from UNITED STATES Additional patient health information: Female patient , child 6 years of age, weighting 39.24 lb, was diagnosed with growth hormone deficiency and. Somatropin dosage: 0.6 Mg, Qd.

6871904-5 | Pituitary Tumour Benign
Adverse event was reported on Jul 15, 2010 by a Male patient taking Somatropin (View Usage) (Dosage: 0.3 Mg, 1x/day) was diagnosed with hypopituitarism and. Location: CZECH REPUBLIC , 22 years of age, weighting 160.9 lb, After Somatropin was administered, patient had the following side effects: pituitary tumour benign. During the same period patient was treated with HYDROCORTISONE (30 Mg, 1x/day) (View Hydrocortisone Review and Hydrocortisone Label ), SUSTANON (250 Mg, Monthly) (View Sustanon Review and Sustanon Label ), LEVOTHYROXINE SODIUM (100 Ug, 1x/day) (View Levothyroxine Sodium Review and Levothyroxine Sodium Label ). Patient was hospitalized.

6866110-4 | Pituitary Tumour Recurrent
on Jul 13, 2010 Male patient from UNITED STATES , weighting 258.2 lb, was diagnosed with growth hormone deficiency, hypothyroidism, hypogonadism, adrenal insufficiency and was treated with Somatropin (View Usage). Patient experienced the following unwanted or unexpected effects: pituitary tumour recurrent. Somatropin dosage: 0.5 Mg, Daily (1/d). During the same period patient was treated with LEVOTHYROXINE SODIUM (0.175 Mg, Unk) (View Levothyroxine Sodium Review and Levothyroxine Sodium Label ), TESTIM (10 G, Daily (1/d)) (View Testim Review and Testim Label ), PREDNISONE (View Prednisone Review and Prednisone Label ).

6863359-1 | Pituitary Tumour Benign
on Jul 09, 2010 Male patient from FRANCE , weighting 216.1 lb, was diagnosed with growth hormone deficiency and was treated with Somatropin (View Usage). Patient had the following side effects: pituitary tumour benign. Somatropin dosage: 0.6 Mg, Daily (1/d). Patient was hospitalized.

6856416-7 | Rathke's Cleft Cyst
Patient was taking Somatropin (View Usage). After Somatropin was administered, patient had the following side effects: rathke's cleft cyst on Jul 12, 2010 from GERMANY Additional patient health information: Female patient , weighting 85.10 lb, was diagnosed with growth hormone deficiency and. Somatropin dosage: .

6844081-4 | Osteonecrosis
Adverse event was reported on Jul 08, 2010 by a Female patient taking Somatropin (View Usage) (Dosage: 1.6 Mg, 1x/day) was diagnosed with turner's syndrome and. Location: COLOMBIA , child 12 years of age, Patient experienced the following unwanted or unexpected effects: osteonecrosis (What is osteonecrosis?).

6836303-0 | Neuromyopathy
on Jul 02, 2010 Male patient from UNITED STATES , weighting 44.09 lb, was diagnosed with growth retardation and was treated with Somatropin (View Usage). Patient had the following side effects: neuromyopathy. Somatropin dosage: 0.9 Mg, 1x/day. During the same period patient was treated with FOSAMAX (Unk) (View Fosamax Review and Fosamax Label ), ARGININE (Unk) (View Arginine Review and Arginine Label ), VITAMIN D (Unk) (View Vitamin D Review and Vitamin D Label ), DEFLAZACORT (Unk) (View Deflazacort Review and Deflazacort Label ), MONTELUKAST SODIUM (Unk) (View Montelukast Sodium Review and Montelukast Sodium Label ), LANSOPRAZOLE (Unk) (View Lansoprazole Review and Lansoprazole Label ), LISINOPRIL (Unk) (View Lisinopril Review and Lisinopril Label ).

6836161-4 | Astrocytoma, Disease Progression
on Jul 08, 2010 Female patient from GERMANY , child 12 years of age, was diagnosed with growth hormone deficiency and was treated with Somatropin (View Usage). After Somatropin was administered, patient had the following side effects: astrocytoma, disease progression. Somatropin dosage: Unk. Patient was hospitalized.

6836116-X | Ischaemic Stroke, Transient Ischaemic Attack
Patient was taking Somatropin (View Usage). Patient experienced the following unwanted or unexpected effects: ischaemic stroke, transient ischaemic attack on Jun 29, 2010 from CZECH REPUBLIC Additional patient health information: Female patient , weighting 134.5 lb, was diagnosed with growth hormone deficiency, hypertension, osteoporosis (What is osteoporosis?), hypopituitarism, hypothyroidism and. Somatropin dosage: 0.4 Mg, Daily (1/d). During the same period patient was treated with AMLODIPINE (View Amlodipine Review and Amlodipine Label ), ALENDRONIC ACID (View Alendronic Acid Review and Alendronic Acid Label ), CALCICHEW (Unk, Unk) (View Calcichew Review and Calcichew Label ), ACETYLSALICYLIC ACID W/DIPYRIDAMOLE (View Acetylsalicylic Acid W/dipyridamole Review and Acetylsalicylic Acid W/dipyridamole Label ), HYDROCORTISONE (15 Mg, Unk) (View Hydrocortisone Review and Hydrocortisone Label ), LEVOTHYROXINE SODIUM (50 Ug, Daily (1/d)) (View Levothyroxine Sodium Review and Levothyroxine Sodium Label ), CHOLECALCIFEROL (View Cholecalciferol Review and Cholecalciferol Label ), LAKEA (50 Mg, Daily (1/d)) (View Lakea Review and Lakea Label ). Patient was hospitalized.

6832327-8 | Osteonecrosis
Adverse event was reported on Mar 17, 2010 by a Female patient taking Somatropin (View Usage) (Dosage: ) was diagnosed with body height below normal, dwarfism (What is dwarfism?) and. Location: JAPAN , 14 years of age, Patient had the following side effects: osteonecrosis (What is osteonecrosis?). Patient was hospitalized.

6826635-4 | Brain Stem Glioma, Neoplasm Recurrence
on Jul 02, 2010 Male patient from SPAIN , child 10 years of age, weighting 105.8 lb, was diagnosed with hypopituitarism and was treated with Somatropin (View Usage). After Somatropin was administered, patient had the following side effects: brain stem glioma, neoplasm recurrence. Somatropin dosage: 1.2 Mg, 1x/day. Patient was hospitalized and became disabled.

6826617-2 | Rectal Cancer
on Jul 06, 2010 Male patient from FRANCE , 60 years of age, weighting 194.0 lb, was diagnosed with hypopituitarism and was treated with Somatropin (View Usage). Patient experienced the following unwanted or unexpected effects: rectal cancer. Somatropin dosage: 0.3 Mg, 1x/day. During the same period patient was treated with LEVOTHYROXINE SODIUM (Unk) (View Levothyroxine Sodium Review and Levothyroxine Sodium Label ), CRESTOR (Unk) (View Crestor Review and Crestor Label ), ANDROTARDYL (Unk) (View Androtardyl Review and Androtardyl Label ), OROCAL VITAMIN D (Unk) (View Orocal Vitamin D Review and Orocal Vitamin D Label ), FOSAMAX (Unk) (View Fosamax Review and Fosamax Label ), DESMOPRESSIN ACETATE (Unk) (View Desmopressin Acetate Review and Desmopressin Acetate Label ).

6818548-9 | Convulsion
Patient was taking Somatropin (View Usage). Patient had the following side effects: convulsion on Jun 22, 2010 from UNITED STATES Additional patient health information: Female patient , weighting 20.94 lb, was diagnosed with pituitary hypoplasia and. Somatropin dosage: 0.5 Mg, Qd.